本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Rocket Pharmaceuticals, Inc.

3.48
+0.07002.05%
盤後3.530.0500+1.44%19:30 EDT
成交量:264.47萬
成交額:921.39萬
市值:3.82億
市盈率:-20.47
高:3.57
開:3.57
低:3.40
收:3.41
52周最高:5.45
52周最低:2.53
股本:1.10億
流通股本:8,496.03萬
量比:1.53
換手率:3.11%
股息:- -
股息率:- -
每股收益(TTM):-0.1700
每股收益(LYR):-2.0100
淨資產收益率:-4.77%
總資產收益率:-28.42%
市淨率:1.04
市盈率(LYR):-1.73

資料載入中...

2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

重要事件披露

Form 8-K - Current report
2025/01/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/16

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/12/12

重要事件披露

Form 8-K - Current report
2024/12/05

重要事件披露

Form 8-K - Current report
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/19

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/07

重要事件披露

Form 8-K - Current report
2024/10/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities